new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




  

Forma Therapeutics Inc patents

Recent patent applications related to Forma Therapeutics Inc. Forma Therapeutics Inc is listed as an Agent/Assignee. Note: Forma Therapeutics Inc may have other listings under different names/spellings. We're not affiliated with Forma Therapeutics Inc, we're just tracking patents.

ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "F" | Forma Therapeutics Inc-related inventors




Date Forma Therapeutics Inc patents (updated weekly) - BOOKMARK this page
03/09/17[6,6] fused bicyclic hdac8 inhibitors
10/27/16Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
10/27/16Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors
10/20/163-spirocyclic-6-hydroxamic acid tetralins as hdac inhibitors
10/20/163-spiro-7-hydroxamic acid tetralins as hdac inhibitors
09/15/16Alpha-cinnamide compounds and compositions as hdac8 inhibitors
09/08/16Tetrahydroquinoline compositions as bet bromodomain inhibitors
09/08/16Benzopiperazine compositions as bet bromodomain inhibitors
09/08/16Tetrahydroquinoline compositions as bet bromodomain inhibitors
09/08/16Benzopiperazine compositions as bet bromodomain inhibitors
08/11/16Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors
08/11/16Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors
08/11/16Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitors
08/04/163-alkyl bicyclic [4,5,0] hydroxamic acids as hdac inhibitors
08/04/163-aryl bicyclic [4,5,0] hydroxamic acids as hdac inhibitors
08/04/16Bicyclic [4,6,0] hydroxamic acids as hdac inhibitors
08/04/163-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as hdac inhibitors
08/04/163-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as hdac inhibitors
06/30/16Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors
06/30/16Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors
03/24/16Pyridin-2(1h)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
03/24/16Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors
03/24/16Pyridin-2(1h)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
03/24/16Pyridinyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
01/07/16Novel compounds and compositions for inhibition of fasn
08/20/15Tetrahydroquinoline compositions as bet bromodomain inhibitors
08/20/15Benzopiperazine compositions as bet bromodomain inhibitors
06/12/14Pyrido-[2,3-d] pyrimidines and their use as kinase inhibitors
06/12/14Pyrido-[2,3-d] pyrimidines and their use as kinase inhibitors
06/12/14Pyrido-[2,3-d] pyrimidines and their use as kinase inhibitors
06/12/14Pyrido-[2,3-d] pyrimidines and their use as kinase inhibitors
06/12/14Pyrido-[2,3-d] pyrimidines and their use as kinase inhibitors
06/12/14Pyrido-[2,3-d] pyrimidines and their use as kinase inhibitors
06/12/14Pyrido-[2,3-d] pyrimidines and their use as kinase inhibitors







ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Forma Therapeutics Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Forma Therapeutics Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';